Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

June 02, 2015 8:40 AM ET


Company Overview of Cosmo Pharmaceuticals S.p.A.

Executive Profile

Alessandro E. Della Chà LL.M

Chief Executive Officer and Director, Cosmo Pharmaceuticals S.p.A.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Alessandro Della Chà, LLM, has been the Chief Executive Officer of Cosmo Pharmaceuticals S.p.A. since March 27, 2014. Mr. Chà is a Senior Partner at Studio Legale Edoardo Ricci e Associati, Milan. Mr. Chà specializes in company law, mergers and acquisitions. He joined the Studio Legale Edoardo Ricci e Associati in 1988. He served as an assistant of the central director for corporate matters of Fininvest Group from 1987 to 1988. He served as the Non-executive Vice ...

Corporate Headquarters

37C, avenue John F. Kennedy
Luxembourg, -- 1855


Phone: 352 2784 8749
Fax: --

Board Members Memberships

Chief Executive Officer and Director
Former Director


Master's Degree
University of Leicester
Universita' degli Studi di Milano

Other Affiliations

Annual Compensation

Total Annual Compensation€1,890,051

Stocks Options

Unexercisable Options€105,000
Total Number of Options€105,000

Total Compensation

Total Annual Cash Compensation€1,890,051
Total Short Term Compensation€1,890,051
Total Calculated Compensation€2,662,238

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
Jack A. Khattar Founder, Chief Executive Officer, President, Secretary and Director
Supernus Pharmaceuticals, Inc.
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cosmo Pharmaceuticals S.p.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at